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Protein modification by covalent coupling of small ligands or markers is an important pre-
requisite for the use of proteins in many applications. Well-known examples are the use of 
proteins with fluorescent markers in many in vivo experiments or the binding of biotinylated 
antibodies via biotin–streptavidin coupling in the frame of numerous bioassays. Multiple 
protocols were established for the coupling of the respective molecules, e.g., via the C 
and N-terminus, or via cysteines and lysines exposed at the protein surface. Still, in most 
cases the conditions of these standard protocols are only an initial guess. Optimization 
of the coupling parameters like reagent concentrations, pH, or temperature may strongly 
increase coupling yield and the biological activity of the modified protein. In order to facili-
tate the process of optimizing coupling conditions, a method was developed which uses a 
compartmented microfluidic reactor for the rapid screening of different coupling conditions. 
In addition, the system allows for the integration of an enzymatic digest of the modified 
protein directly after modification. In combination with a subsequent MALDI-TOF analysis 
of the resulting fragments, this gives a fast and detailed picture not only of the number and 
extent of the generated modifications but also of their position within the protein sequence. 
The described process was demonstrated for biotinylation of green fluorescent protein. 
Different biotin-excesses and different pH-values were tested in order to elucidate the 
influence on the modification extent and pattern. In addition, the results of solid-phase 
based modifications within the microfluidic reactor were compared to modification patterns 
resulting from coupling trials with unbound protein. As expected, modification patterns of 
immobilized proteins showed clear differences to the ones of dissolved proteins.
Keywords: protein modification, solid-phase reaction, enzymatic digest, microfluidic reactor, biotinylation
inTrODUcTiOn
The synthetic modification of proteins has many applications in biotechnology. By use of chemi-
luminescent or fluorescent dyes proteins can be made visible in  vitro and in  vivo (Gillespie and 
Hudspeth, 1991; Ballou et al., 1995; Han et al., 2015; Press et al., 2016). Physicochemical properties 
(solubility, stability) can be altered (Xiao et al., 2008; Morgenstern et al., 2017), or proteins can be 
FigUre 1 | Chemical structure of N-hydroxysuccinimide (NHS)–biotin.
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activated for immobilization or cross-linking (Tang and Bruce, 
2009; Hutsell et al., 2010). A comprehensive and detailed collec-
tion of modification reactions and protocols were given in several 
books and publications (Wu and Goody, 2010; Hermanson, 2013; 
Boutureira and Bernardes, 2015).
For protein immobilization, biotin plays an important role. 
Biotin is a 244.31-Da molecule, which takes part in important 
metabolic processes in nature (McMahon, 2002). It is known for 
its unusually strong non-covalent interaction with avidin. The 
dissociation constant is 10−15 M (Guesdon et al., 1979) and is thus 
higher than the one of antibodies and their antigen (Diamandis 
and Christopoulos, 1991). Avidin is a 66-kDa glycoprotein from 
eggwhite, consisting of four subunits with 16.4 kDa each (Green, 
1975). Each subunit is capable of binding one biotin.
Due to the strong bond between biotin and avidin, the 
biotinylation of proteins is used for affinity chromatography, 
immunoassays, or immobilization. A well-established reaction 
for the biotinylation of proteins is the use of reactive groups 
like the amine-reactive N-hydroxysuccinimide (NHS) or the 
sulfur-reactive maleimide. The structure of biotin–NHS is given 
in Figure 1. NHS–biotin reacts mainly with the terminal amine 
or lysines, which are present on the surface of proteins with 
high frequency (Sokalingam et al., 2013). The reactivity of NHS 
groups depends on multiple factors like pH-value or temperature 
which influence the amount of modified lysines. For each pro-
tein, screening of these conditions is a necessary prerequisite for 
yield optimization, but can be time consuming. We developed 
a compartmented, microfluidic reactor system which allows the 
parallel evaluation of several reaction conditions for biotinylation. 
A subsequent on-line enzymatic digest followed by an off-line 
mass spectrometric measurement allows a fast and detailed 
analysis of the resulting reaction products.
Compartmentalization of the reactor is achieved in the reaction 
capillary by inserting aqueous reaction phases followed by non-
mixable (organic) solvents or air. For protein modification, the 
reaction phases consist of aqueous buffers filled with reactants or 
enzymes. The target protein is immobilized on magnetic particles 
and can be transported through the reactor. A relative movement 
between plugs and the immobilized protein is achieved by fixing 
the magnetic particles with an external bar magnet and pump-
ing the reactor content further until the desired plug is reached. 
Thus, the particles can sequentially enter reaction plugs filled 
with different reactants and react accordingly. In Hübner et al. 
(2015), a precursor of the reactor was presented. In this study, 
we show an important enhancement of the reactor and its use 
for the screening of biotinylation conditions. Experiments with 
free eGFP were conducted under the same conditions in order to 
show whether differences in the isomer formation occur for the 
immobilized protein.
MaTerials anD MeThODs
chemicals and Materials
Chemicals used for this work are given in the following. Sinapic 
acid, α-cyano-4-hydroxycinnamic acid (CHCA), pepsin from 
porcine pancreas, trifluoroacetic acid (TFA), biotin NHS ester 
(NHS-Biotin), and ammonium bicarbonate (NH4HCO3) were 
purchased from Sigma Aldrich (St. Louis, MO, USA), Pierce BCA 
protein assay kit from Thermo Scientific (Waltham, MA, USA).
Albumin fraction V from bovine serum, sodium dihydrogen 
phosphate dihydrate, ethanolamine, copper(II) sulfate pentahy-
drate, hydrochloric acid (32%), pH-indicator strips MColorpHast 
(pH 0–14), pH-indicator strips pH 5–10, and sodium chloride 
were purchased from Merck Millipore (Darmstadt Germany); 
dimethyl sulfoxide (DMSO) from VWR (Radnor, PA, USA). 
Disodium hydrogen phosphate and sodium hydroxide were 
ordered from Carl Roth GmbH & Co. KG (Karlsruhe, Germany); 
disuccinimidyl suberate (DSS) was ordered from Cayman 
Chemical Company (Ann Arbor, MI, USA).
The plasmid for eGFP production was generated at the Institute 
of Industrial Genetics of the University of Stuttgart, Germany. 
The plasmid pJOE4056 was used as vector for the fusion of 
the (His) 6-tag. The protein was expressed by Escherichia coli  
(E. coli) BW3110 at the Institute of Biochemical Engineering of the 
University of Stuttgart, Germany. Fermentation was conducted as 
described by Wilms et al. (2001).
Magnetic micro particles with iminodiacetic acid functionali-
zation (IDA-particles), with carboxy functionalization (C22) and 
with N,N-diethyl-1,3-propanediamine functionalization (DEAP) 
were kindly donated by PerkinElmer chemagen Technologie 
GmbH (Baesweiler, Germany). Capillaries consisted of fluori-
nated ethylene propylene and were purchased from Wolf-Technik 
(Stuttgart, Germany) with an outer diameter of 3.17 mm and an 
inner diameter of 1.58 mm.
analytical Methods
Protein Immobilization and Quantification
The concentration of the bead suspension was determined gravi-
metrically before protein immobilization. For this, 200 µL of the 
bead suspension were dried at 60°C in triplicates in pre-weighed 
HPLC glass vials in a drying oven Heraeus Function Line serie 
7000 B6 from Heraeus (Hanau, Germany). After drying of the 
particles, vials were weighed again on a microbalance Sartorius 
MC 5 (Göttingen, Germany) and the concentration was calcu-
lated. eGFP with His-tag was immobilized on IDA-functionalized 
particles. The particles were first activated with a solution of 
50 mM CuSO4, 0.2 M NaCl, pH 4.2 (activation solution). 10 mg 
particles were mixed with 1.5 mL activation solution at 25°C and 
1,400 rpm for 1 h. Particles were washed with 50 mM phosphate 
buffer pH 7.5 (storage buffer) once and between 0.3 and 1.6 mg 
protein in solution were added. Immobilization was conducted 
FigUre 2 | Scheme for analysis of the biotinylated modification sites.
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for 1  h at 25°C and 1,400  rpm. A Thermomixer comfort 5355 
by Eppendorf AG (Hamburg, Germany) was used for mixing 
and tempering of immobilization and modification reactions in 
reaction vessels.
Afterward, the beads were washed with 10  mM phosphate 
buffer, 0.8 M NaCl, pH 7.5 (washing buffer) three times, twice 
with storage buffer and the supernatants were collected. By use of 
a BCA-Assay protein concentrations in the washing supernatants 
and the eGFP stock solution were determined. BSA solutions 
with different concentrations in the same buffer were applied for 
calibration. Absorption was measured in multititer plates with 
96 wells from Brand (Wertheim, Deutschland) in a plate reader 
EnSpire 2300 Multimode from PerkinElmer (Waltham, MA, 
USA).
Protein loading was calculated from the difference of the 
protein mass applied for immobilization (mProtein) and the protein 
mass not bound (mProtein, supernatant) and washed off (mProtein, wash). The 
difference was divided by the particle mass (mParticle), as described 
in Eq. 1.
 
Load Protein Protein Supernatant Protein Wash
Particl
=
− +m m m
m
( ), ,
e
.
 
(1)
Mass Spectrometric Measurements
Mass spectrometric measurements were performed in a MALDI 
TOF/TOF 4800 analyzer (Applied Biosystems, Framingham, 
MA, USA), either in linear mode or in reflector mode. Samples 
for MALDI-measurements were diluted 1:25 with the matrix 
solution. For the linear mode, 10 mg/mL sinapic acid in 50% (v/v) 
acetonitrile with 0.1% TFA were used as matrix, for the reflector 
mode 10 g/L CHCA in 50% acetonitrile with 1% TFA. 0.5–1 µL 
of each sample-matrix solution and a calibration mix were 
spotted onto a MALDI stainless steel target. Dried spots were 
measured via MALDI TOF/TOF. MALDI measurements were 
analyzed with Data Explorer Software 4.0 (Applied Biosystems). 
Further analysis was done with the open source software mmass 
(Strohalm et al., 2010). Spectra in linear mode were smoothed 
using a Savitzky–Golay filter with a window size of 50 m/z and 
five cycles in the software “mmass.”
For measurements in reflector mode, a list of the peptide 
masses in the spectrum was generated by the built-in tool in the 
Data Explorer Software 4.0. In order to prove the successful pro-
teolytic digest of the protein, the generated list was entered in the 
databank “MASCOT Peptide Mass Fingerprint” (Perkins et al., 
1999). This software calculates which organism correlates most 
with the entered data. For the determination of peptide fragments 
after an enzymatic digest the tool “PeptideMass” from Expasy was 
used (Wilkins et al., 1997).
Digest of Free and immobilized Protein
The analysis of the modified amino acids requires a fragmentation 
of the protein, which is achieved here with the protease pepsin. For 
the digest of immobilized protein 0.3 mg eGFP on IDA-particles 
were applied. The protein was immobilized and then washed with 
0.1 M citrate buffer pH 2. The buffer was replaced by 100 µL of a 
1 g/L pepsin solution in 0.1 M citrate buffer pH 2. The samples 
were digested for 21–22 h at room temperature on a shaker. The 
reaction was stopped by addition of 30  µL of 1  M NaOH per 
100 µL sample and prepared for MALDI measurement.
For free protein, buffer exchange was performed using cen-
trifugal concentrators Vivaspin®. The buffer of 0.3  mg of free 
protein was replaced by 0.1 M citrate buffer pH 2 and 100 µL of 
1 g/L pepsin solution were added. The following sample prepara-
tion corresponded to the one for immobilized protein.
Determination of Modification sites
The enzymatic digest and mass spectrometric analysis of the 
digest product can be used for determination of the biotinylated 
lysines. Identification of the modification sites occurred accord-
ing to a protocol, which is summarized in Figure  2. First, the 
theoretic cleavage sites of pepsin for eGFP were determined using 
“PeptideMass” from Expasy. The resulting peptide fragments and 
their masses were calculated with this information. The mass of 
bound biotin (226.078 g/mol) was added to the theoretic peptide 
masses and the masses were deposited in a file (“peptides with bio-
tin”). The mass spectra of the unmodified eGFP were compared to 
the spectra of the modified eGFP afterward in order to find differ-
ences. Lists were created with those peptide masses, which were 
only present in the spectra of the modified proteins (“potentially 
biotinylated peptides”). The potentially biotinylated peptides 
were compared to the list of “peptides with biotin.” Agreements 
were only assumed with mass differences below 0.2 Da and with 
at least one lysine in the peptide sequence. Additionally, it had to 
be found in all spectra of the triplicates per run. For verification, 
MS/MS Measurements were performed. MS/MS measurements 
allow for a more detailed fragmentation of a mass that was found 
in the spectrum of a sample. This delivers further information 
about the peptide. A voltage of 1 kV was used for fragmentation. 
Only if the MS/MS measurements confirmed the modification of 
a peptide, a successful reaction was assumed.
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Protein Modification reactions
Protein modification was either performed using different pH-
values or different molar excesses of NHS-biotin compared to the 
applied eGFP. For the excess-experiments NHS-biotin was used 
in a 10-, 20-, 50-, or 100-fold molar excess compared to the 0.1 mg 
immobilized protein per reaction. The particles were inserted 
into the reactor in a 10-g/L suspension in storage buffer with 15% 
DMSO. A stock solution with 1.8 g/L Biotin-NHS was made and 
diluted 1:20 in a solution of 40% DMSO and 60% storage buffer. 
For reduction of the biotin excess the stock solution was further 
diluted.
Mixing was achieved by pumping 50 µL with a flow rate of 
20 µL/s forth and back. The digest was performed in the reactor 
as described in Section “Digest of Free and Immobilized Protein.” 
For comparison, the reaction was also conducted with free protein 
in micro centrifuge tubes under equal conditions. This reaction 
was stopped by adding 100 µL of an ethanolamine solution pH 7 
with a 30-fold excess compared to biotin.
The experiments for screening of pH-values were performed 
using 0.3 mg immobilized eGFP. The magnetic particles with the 
immobilized GFP were pumped into the reactor in a suspension 
with storage buffer and 15% DMSO. Depending on the desired 
pH-value, magnetic ion exchange particles were also pumped 
into the reactor in another plug. They were then moved to the 
reaction plug, which contained a 20-fold molar excess of biotin-
NHS (compared to 0.3  mg eGFP). By mixing the particles in 
the reaction plug for 5 min, the pH was changed as desired (see 
Change of pH-Value in the Reactor Device). After removal of the 
ion exchange particles, the particles with the immobilized eGFP 
were moved to the reaction plug and the modification took place 
for 5 min. After the reaction, the particles were pumped out of the 
reactor and washed. The pH-value of the plug was controlled with 
pH-indicator strips. Half of the particles were used for protein 
elution in a solution 0.5% NH4HCO3 in water twice for 15 min 
and measured in linear mode. The other half was digested by 
pepsin and measured via MALDI in reflector mode. The reaction 
was also performed with free protein under the same conditions. 
This reaction was stopped by adding 100 µL of an ethanolamine 
solution pH 7 with a 30-fold excess compared to biotin and then 
prepared for digest and analysis as given in Section “Digest of Free 
and Immobilized Protein.”
change of ph-Value in the reactor Device
Magnetic ion exchange particles were used to adjust the pH-value 
in selected plugs inside the reactor. 3 mg particles with carboxy 
functionalization (C22) could be used to lower the pH-value 
of 100 µL storage buffer to pH 6.5. 3.8 mg particles with N,N-
diethyl-1,3-propanediamine functionalization (DEAP) increased 
the pH-value of 100 µL storage buffer to pH 8. C22 particles were 
first activated by shaking 54 mg particles in 2 mL 1 M HCl for 
10 min. 62 mg DEAP particles were shaken for 10 min in 2 mL 
1 M NaOH. The particles were washed with MilliQ and stored 
therein.
Titration curves of Magnetic Particles
The titration curves of the magnetic particles were determined 
as described by Paulus et al. (2015). For this 20 mg particles were 
washed in a solution of 0.01 M NaOH and then resuspended in 
10 mL of the same solution. A solution of 0.1 M HCl was added 
step-wise. The particles were separated by use of a magnet and 
the alteration of the pH-value was measured. Both DEAP and 
C22 particles were used and titration curves were determined 
twice. The pKa was determined at the inflection point between 
the plateaus (Stipanuk and Caudil, 2012). For the DEAP parti-
cles, the method of Frimmel et al. (1985) was applied addition-
ally. First, the titration curve for water was substracted from the 
DEAP titration curve. In order to achieve this, interpolations 
were performed for the curves, respectively, and the difference 
of the curves was plotted versus the pH-value. The derivative 
of the resulting difference plot was formed. For calculating 
the derivative, the difference plot was approximated to a ninth 
order polynomic function. The maximums of the derivative plot 
represent the pKa.
resUlTs anD DiscUssiOn
reaction Device
In this study, we present an enhanced version of the reaction 
device presented in Hübner et al. (2015). A schematic is given in 
Figure 3. The syringe pump in “pulling mode” pulls the liquids 
from the reservoir area (storage of buffers, solvents, and reactant 
solutions) into the reaction area. In the reaction area, the reac-
tion capillaries are arranged between valve 2 and valve 3 and are 
filled with reaction and separation plugs. Other than depicted in 
the scheme, each valve contains 10 ports. As two ports of valve 
3 serve as output ports, eight reaction capillaries are available 
for reactions. The syringe pump and the valves are controlled by 
the software QmixElements (Cetoni, Korbußen, Germany), thus 
allowing a semi-automated operation of the reaction device.
The main control unit as well as the modules with a syringe 
pump or multiport valves, respectively, were purchased from 
cetoni GmbH (Korbußen, Germany) and consisted of a Qmix 
base module “BASE 600,” three low pressure valve modules 
“Qmix V EX” and a “neMESYS” low pressure syringe pump. 
Whereas in former studies only one reaction capillary was pre-
sent, parallelization is achieved here by use of three valves. This 
allows for the introduction of eight reaction capillaries which are 
usable in parallel. This leads to a significant reduction of experi-
ment duration. In the original version of the device mixing of the 
magnetic beads in the reactor was mainly achieved by Helmholtz 
coils inducing a magnetic field. In the case of parallelized reaction 
capillaries efficient mixing is achieved by pumping the reactor 
content forth and back for a few microliters. The particles are 
dispersed inside the plug by this movement. This way, scale-up of 
the electromagnetic coils and the requirement of cooling of the 
coils is not necessary anymore.
Digest and identification of the 
immobilized Protein
eGFP is a very stable protein that is hardly digestible at neutral 
pH-values (Chiang et al., 2001). A digest can, however, be per-
formed in an acidic medium (Alkaabi et al., 2005), e.g., by the 
protease pepsin at pH 2. This reaction was already used with free 
FigUre 3 | Setup of the compartmented reactor system. (a) Scheme showing the different areas. (B) Photo showing the actual system.
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eGFP as a sensor for pepsin activity (Malik et al., 2005). Before 
the MALDI-TOF analysis could be used for process validation, 
the applicability of a solid-phase digest by pepsin needed to be 
verified. The digest of free and immobilized protein was com-
pared, in order to prove that the reaction is similarly efficient. 
Samples were prepared as described in Section “Digest of Free 
and Immobilized Protein” and measured via MALDI in the 
reflector mode. By use of “MASCOT Peptide Mass Fingerprint” 
and adjustment of the search parameters peptide tolerance 
(altered between 1–2 Da) and missed cleavages (altered between 
0 and 2) the samples were assigned to GFP. Due to the high 
sequence identity of GFP and eGFP of 98.8%, a successful 
solid-phase digest and assignment can be assumed for both 
reactions. The sequence of the used eGFP clone is given in the 
Supplementary Material.
In order to further compare the digest of the free and the 
immobilized protein, protein sequence coverage was considered. 
This value is given by the software during analysis. For this value, 
the peptides identified during the mass spectrometric measure-
ments are aligned with the amino acid sequence of the considered 
protein. The protein sequence coverage specifies the portion of 
amino acids that was covered during this alignment. Therefore, it 
expresses the efficiency of the digest and detection. For the digest 
of the free and immobilized protein, this value should be as similar 
as possible. A protein sequence coverage of 0.53 was determined 
for the immobilized and 0.56 for the free protein with a peptide 
tolerance of 0.2  Da and one missed cleavage. These values are 
very close. Thus, the digest appears to be similarly effective in 
both systems.
analysis of Modification sites
In the preceding section, it was shown that eGFP can be suc-
cessfully digested in a solid-phase reaction with an efficiency 
equal to the digest of free protein. Consequently, an enzymatic 
digest followed by mass spectrometry can be used to analyze and 
optimize the reaction conditions for solid-phase biotinylation 
of eGFP. In a first series of experiments different biotin-excesses 
were examined, followed by a second series in which the reaction 
pH was varied.
Modification with Different Biotin-Excesses
In this experimental series, the biotin excess was varied by apply-
ing a molar ratio of 10, 20, 50, and 100 relative to the applied 
0.1  mg immobilized eGFP. After the coupling, the reaction 
products were digested in parallel and the exact positions of the 
generated modification were determined following the protocol 
in Section “Protein Modification Reactions.” The list of modified 
lysines depending on the applied excess is given in Table 1. NHS-
biotin attacks mainly amines, e.g., lysines or the N-terminus of the 
protein. As the His-tag of the eGFP is located at the N-terminus, 
biotinylation of the N-terminus is not regarded here. From the 
list it becomes clear that the lysines are modified in a sorted way: 
If a lysine is modified for a smaller biotin-excess, it is also modified 
with a higher excess. This indicates that the order of modification 
is not random. Additionally, the higher the excess of NHS-Biotin, 
the more lysines are modified, as was expected.
Using free protein, a higher number of lysines was modified 
for almost each case. Consequently, solid-phase biotinylation 
reduces the extent of biotinylation which is probably due to steric 
FigUre 4 | (a) Titration curves of the DEAP, C22 particles, and water as 
control. 20 mg particles in 10 mL of a solution of 0.01 M NaOH were titrated 
with 0.1 M HCl. (B) For determination of an additional pKa of the DEAP 
particles, a difference plot of the DEAP and water titration curve was created 
and derived.
TaBle 1 | Modified lysines for the biotinylation with different excesses of 
biotin–N-hydroxysuccinimide.
Different excesses Different excesses
solid-phase reaction reaction with free protein
10× 20× 50× 100× 10× 20× 50× 100×
K 79 K79 K26 K26 K26 K26 K26 K26
K 107 K85 K79 K79 K85 K85 K79 K79
K 113 K107 K107 K85 K107 K101 K85 K85
K 156 K113 K113 K107 K113 K107 K101 K101
K 158 K126 K126 K113 K126 K113 K107 K107
K 162 K131 K131 K126 K140 K126 K113 K113
K156 K140 K131 K209 K131 K126 K126
K158 K156 K140 K214 K140 K131 K131
K162 K158 K156 K166 K140 K140
K209 K162 K158 K214 K156 K156
K214 K209 K162 K158 K158
K214 K209 K162 K162
K214 K166 K166
K214 K209
K214
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hindrance and reduced accessibility of reaction sites. In addition, 
temporary fixation of the substrate onto the solid-phase strongly 
reduces its mobility and, therefore, the collision probability 
between the protein and NHS-PEG. In consequence the reac-
tion rate is reduced which may also lead to a smaller number 
of modified lysines. For a preferably complete conversion high 
excesses of NHS-biotin are thus necessary. The difference in the 
number of modified lysines ranged from two to four. On the one 
hand, this indicates a lower efficiency for the solid-phase reac-
tion. On the other hand, this can be regarded as a step toward 
a more specific biotinylation reaction via NHS-biotin, since a 
more homogenous product is formed. This can be advantageous 
for certain applications. However, as MALDI-TOF as qualitative 
method was chosen for analysis, no quantitative conclusions can 
be drawn which would deliver further information.
The solid-phase reaction also did not only reduce the number 
of modified lysines but also changed their composition: K101 and 
K166 were only modified in solution and not in the solid-phase 
reaction. Thus, by use of the solid-phase reaction certain lysines 
can be excluded from the modification reaction which can be 
useful for reaction control. Possible causes for this are shielding 
of amino acids by the particle surface and steric effects close to 
the carrier. Maiser et al. (2015) observed a change in the isoform 
composition after comparing solid-phase PEGylation with 
PEGylation of free protein. They were able to lead this difference 
back to steric effects. However, the PEG applied in this study was 
larger (kDa) than the biotin used here so that steric hindrance 
has a smaller effect.
To our knowledge, these experiments represent the first 
reaction cascade combining protein modification and enzymatic 
digest, thus sample preparation, in a compartmented microfluidic 
device.
Modification at Different pH-Values
In a second set of experiments the influence of the pH-value on 
solid-phase biotinylation was investigated. As the NHS-group 
is subject to pH-dependent hydrolysis, which might falsify the 
results, we first investigated a method for an in  situ change of 
the pH in the reactor. By changing the pH-value right before the 
modification reactions, a pH-dependent hydrolysis of NHS can 
be minimized.
A unique feature of the developed microfluidic reactor is 
its capability to transfer magnetic micro particles in and out 
of the compartmented plugs in which the reaction takes place. 
Therefore, besides serving as carriers for solid-phase protein 
modification, other types of magnetic particles can also be used 
for pH adjustment. For these magnetic micro particles with 
carboxy or DEAP, functionalities were used as source or sink 
of protons. The titration curves for both particles are given in 
Figure  4. Both particle types possess a plateau between pH 6 
and pH 7.5 which leads to a pKa of ca. 6.75. This pKa results 
TaBle 2 | Modified lysines by use of different pH-values for immobilized and free 
eGFP.
Different ph-values Different ph-values
solid-phase reaction reaction with free protein
pH 6.5 pH 7.5 pH 8.0 pH 6.5 pH 7.5 pH 8.0
K101 K101 K26 K26 K26 K26
K107 K107 K85 K107 K85 K85
K113 K113 K101 K113 K107 K101
K140 K126 K107 K126 K113 K107
K209 K131 K113 K140 K126 K113
K214 K140 K126 K209 K140 K126
K156 K131 K214 K156 K131
K158 K140 K158 K140
K162 K156 K162 K156
K214 K158 K209 K158
K162 K214 K162
K209 K209
K214 K214
FigUre 5 | Mass spectra after biotinylation of eGFP at different pH-values. A 
20-fold excess of biotin compared to the used 0.3 mg protein was applied.
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from the carboxy groups of the particles. This pKa can also be 
determined for the DEAP particles as they are synthesized on 
the basis of the carboxy particles (Müller et al., 2011). It is likely 
that the conversion was not complete, so that carboxy groups 
are still present on the surface. Starting at around pH 10, the 
titration curves of the particle suspensions separate from the 
titration curve for water. For the DEAP particles this indicates 
buffering by amine-groups. For the DEAP particles an additional 
pKa of 9.3 was determined by use of the method by Frimmel et al. 
(1985). From the titration curves, it can be seen that because of 
their functional groups the particles are suitable for alteration 
of the pH-value inside the reactor. Depending on the amount of 
particles applied, particles with carboxy groups in the protonated 
form are able to decrease the pH down to about pH 6. In contrast, 
particles with DEAP groups can increase the pH up to approx. 
pH 10. The limited pH-range is caused by the use of weak acids 
and bases as functional groups. If functional groups with strong 
dissociation behavior had been used instead, the accessible pH-
range could be strongly enhanced.
By use of the in  situ pH-control, solid-phase biotinylation 
was performed at the pH-values 6.5, 7.5, and 8.0 in the reactor 
with a 20-fold biotin-excess as described in Section “Protein 
Modification Reactions.” After 5 min reaction time, the reaction 
plug was withdrawn from the reactor into the fractionation area. 
Half of the particles were separated and protein was eluted for 
MALDI measurements in linear mode. The results of the meas-
urements are shown in Figure  5. Subsequently, the enzymatic 
digest was performed with the remaining particles.
The measurements in linear mode allow for a first characteri-
zation of the reaction: a lower pH-value leads to a reduced modi-
fication. Fewer biotins were bound to the protein than for higher 
pH-values, as becomes clear from the lower molecular weights. 
In the solid-phase reaction, a mass of up to 29,970 Da was mea-
sured which corresponds to five coupled biotin molecules.
The ratio of modified to unmodified protein (mass of about 
28,890 Da) gives a relative impression of the extent of the yield. 
The higher the pH-value the less unmodified protein is present. 
Apparently, the reaction is accelerated at higher pH-values. This 
is in accordance with literature (Nojima et al., 2009; Maiser et al., 
2014). For more detailed information, the samples were also 
digested by pepsin and then measured by MALDI in reflector 
mode and with MS/MS, in order to identify the modified amino 
acids. The modified lysines are given in Table 2. As in the experi-
ment with different biotin-excesses, the modified biotins appear 
in a sorted way: If a lysine is modified at a lower pH-value, it 
also is for a higher value. It should be mentioned that this is not 
necessarily the case, e.g., for coupling with aldehydes, it has been 
observed that the modified lysines alter depending on the pH-
value (Maiser et al., 2014).
As can be seen in Table 2, the modified lysines also indicate 
that a higher pH-value leads to an increased biotinylation both 
for free and immobilized protein. Regarding the modified lysines, 
the differences between the solid-phase reaction and reaction 
with dissolved protein are less significant than for the experi-
ments using different excesses of NHS-biotin. This might be due 
to the shorter reaction time used for the pH-experiments (5 min 
instead of 60 min for different excesses). A longer reaction time 
might lead to a higher number and a higher variety of modified 
amino acids.
The number of coupled biotins is not equal for the measure-
ment in linear and in reflector mode. One reason for this is 
the formation of isomers: Despite the same number of bound 
biotins, different eGFP molecules apparently have the biotins 
bound to different positions. As consequence, more modified 
lysines were measured altogether than bound per eGFP in the 
reflector mode.
cOnclUsiOn
In this study, we were able to enhance and apply a compart-
mented, microfluidic reactor for protein modification reactions 
and subsequent sample preparation for detailed analysis of the 
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reaction products. On the one hand, it was possible to parallelize 
the reactor so that multiple experiments were feasible in parallel. 
On the other hand, the reactor could be applied for the screen-
ing of different reaction conditions: pH-value, and the excess of 
NHS-biotin was varied. Modification was directly coupled with 
enzymatic digest and, thus, with sample preparation. A detailed 
analysis of the modified lysines was possible by use of mass 
spectrometric methods.
As expected, a higher excess of NHS-biotin and a higher pH-
value lead to an increased conversion. Additionally, the modified 
lysines appeared to react in a specific order. Furthermore, it was 
observed that the modification of immobilized proteins varied 
from the respective modification of free proteins in the amount 
of modified lysines, but partly also in the location of the modifica-
tion. Both aspects might be useful for process control.
Reactant concentration and pH-value were screened in this 
study, but also other conditions like reaction duration are possi-
ble. The same is valid for the reaction types which can be studied: 
Various modification reactions in aqueous buffer are thinkable 
in the reactor and besides biotinylation also PEGylation has 
been investigated in a former study with a simpler version of 
the reactor. As was additionally shown, enzymatic solid-phase 
reactions are also possible within the system. Thus, in future 
a wide range of more complex solid-phase reactions can be 
performed in the reactor, like, e.g., glycosylation of immobi-
lized proteins.
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